Correspondence re: Y. S. Haviv,J. L. Blackwell,A. Kanerva,P. Nagi,V. Krasnykh,I. Dmitriev,M. Wang,S. Naito,X. Lei,A. Hemminki,D. Carey,and D. T. Curiel,Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res., 62: 4273-4281, 2002 |